AtomVie Global Radiopharma Funding: $90M Raised, Series A
AtomVie Global Radiopharma is based in Hamilton, Ontario, Canada. It has raised $90M in total funding. Latest round: Series A.
AtomVie Global Radiopharma funding overview
AtomVie Global Radiopharma is based in Hamilton, Ontario, Canada. AtomVie Global Radiopharma has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2023. The round record for AtomVie Global Radiopharma runs through 2023; nothing later has been disclosed. Investors on record include Avego Management, Avego Healthcare Capital. 2 distinct backers are named across the disclosed rounds.
AtomVie Global Radiopharma at a glance
Total raised
$90M
Latest round
Series A
Latest round date
June 2023
Headquarters
Hamilton, Ontario, Canada
Notable investors
Avego Management, Avego Healthcare Capital
Frequently asked about AtomVie Global Radiopharma funding
How much has AtomVie Global Radiopharma raised?
AtomVie Global Radiopharma has raised $90M in total disclosed funding across the rounds on record.
Who has invested in AtomVie Global Radiopharma?
Avego Management, Avego Healthcare Capital are named among the investors backing AtomVie Global Radiopharma.
What was the latest AtomVie Global Radiopharma funding round?
The most recent disclosed round is a Series A, announced in June 2023.
Where is AtomVie Global Radiopharma based?
AtomVie Global Radiopharma is based in Hamilton, Ontario, Canada.
When did AtomVie Global Radiopharma last raise?
The last disclosed AtomVie Global Radiopharma round closed in June 2023 at Series A.
AtomVie Global Radiopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hamilton below to benchmark round size and investor mix.
Companies related to AtomVie Global Radiopharma (40)
